Full Text View
Tabular View
No Study Results Posted
Related Studies
Investigation of the Cylex® ImmuKnow® Assay
This study is currently recruiting participants.
Study NCT00569842   Information provided by Indiana University
First Received: December 5, 2007   Last Updated: August 21, 2009   History of Changes

December 5, 2007
August 21, 2009
November 2007
November 2009   (final data collection date for primary outcome measure)
 
 
Complete list of historical versions of study NCT00569842 on ClinicalTrials.gov Archive Site
 
 
 
Investigation of the Cylex® ImmuKnow® Assay
Investigation of the Cylex® ImmuKnow® Assay

Currently, there is no accurate way of predicting the occurrence of Graft vs Host Disease (GvHD) or infection. The purpose of this study is to analyze blood with the ImmuKnow® Assay to see if doctors can detect which patients are at risk for GvHD and for getting an infection before they occur.

 
 
Observational
Case-Only, Prospective
  • Leukemia
  • Non-Hodgkin's Lymphoma
  • Chronic Lymphocytic Leukemia
  • Hodgkin's Disease
  • Multiple Myeloma
  • Myelodysplastic Syndromes
  • Myeloproliferative Disorders
  • Aplastic Anemia
  • Chronic Myelogenous Leukemia
 
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Recruiting
30
November 2010
November 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

Patients who are undergoing allogeneic HSCT using a myeloablative preparative regimen for any of the following disorders are eligible:

  1. Acute leukemia
  2. Non-Hodgkin's Lymphoma
  3. Chronic lymphocytic leukemia
  4. Hodgkin's disease
  5. Multiple myeloma
  6. Myelodysplastic Syndromes
  7. Myeloproliferative Disorders
  8. Aplastic Anemia
  9. Chronic myelogenous leukemia
Both
18 Years and older
No
Contact: Lisa Wood, RN 317-274-1781 llwood@iupui.edu
Contact: Sherif Farag, MD, PhD 317-274-0843 ssfarag@iupui.edu
United States
 
NCT00569842
Sherif Farag, MD, PhD/ Principal Investigator, Indiana University Cancer Center
0710-11/ IUCRO-0207
Indiana University School of Medicine
 
Principal Investigator: Sherif Farag, MD, PhD Indiana University Simon Cancer Center
Indiana University
August 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP